Although cortical sclerostin expression correlated with bone FGF23 expression in all patients (r = 0.38, p<0.05), in contrast to bone FGF23, cortical sclerostin tended to be lower in non-transplanted CKD patients than in controls (p = 0.056). Here, SOST is linked to chronic kidney disease.